| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
serine protease 1 | 0.563 | 0.692 | 4.1E-11 |
|
disease | 0.700 | None | 0.941 | 68 | 14 | 1997 | 2020 | ||||||||
|
cannabinoid receptor 2 | 0.509 | 0.846 | 6.5E-06 |
|
disease | 0.510 | None | 1.000 | 2 | 0 | 2007 | 2009 | ||||||||
|
serine peptidase inhibitor Kazal type 1 | 0.492 | 0.808 | 0.31 |
|
disease | 0.500 | None | 0.944 | 71 | 2 | 1996 | 2020 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.500 | None | 0.936 | 47 | 7 | 1998 | 2020 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
disease | 0.500 | None | 1.000 | 30 | 5 | 1996 | 2020 | ||||||||
|
calcium sensing receptor | 0.410 | 0.846 | 4.7E-02 |
|
disease | 0.460 | None | 0.667 | 6 | 4 | 1996 | 2014 | ||||||||
|
claudin 2 | 0.575 | 0.692 | 0.70 |
|
disease | 0.420 | None | 1.000 | 2 | 3 | 2012 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.390 | None | 1.000 | 10 | 0 | 2002 | 2018 | ||||||||
|
cholecystokinin | 0.453 | 0.846 | 3.3E-05 |
|
disease | 0.370 | None | 1.000 | 9 | 0 | 1998 | 2020 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.360 | None | 0.857 | 7 | 2 | 2006 | 2018 | ||||||||
|
nuclear protein 1, transcriptional regulator | 0.606 | 0.615 | 4.2E-03 |
|
disease | 0.340 | None | 1.000 | 5 | 0 | 2006 | 2019 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2006 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2007 | 2018 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2008 | 2019 | ||||||||
|
somatostatin | 0.399 | 0.885 | 0.34 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 1994 | 2019 | ||||||||
|
microRNA 375 | 0.476 | 0.769 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2016 | 2019 | |||||||||
|
microRNA 216a | 0.582 | 0.654 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2015 | 2018 | |||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2014 | 2018 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2010 | 2017 | ||||||||
|
microRNA 214 | 0.480 | 0.808 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2016 | 2020 | |||||||||
|
microRNA 30a | 0.478 | 0.808 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2016 | 2017 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2016 | 2019 | |||||||||
|
transient receptor potential cation channel subfamily V member 1 | 0.446 | 0.885 | 1.0E-16 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2007 | 2007 | ||||||||
|
microRNA 429 | 0.544 | 0.731 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
microRNA 148a | 0.506 | 0.846 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 |